Ulrike Harjes
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 11
- Cancer Genomics and Diagnostics 7
- Cancer, Lipids, and Metabolism 7
-
- Epigenetics and DNA Methylation 6
- Peroxisome Proliferator-Activated Receptors 5
-
- Immune cells in cancer 5
-
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 6
- Co-authors
- Peter CarmelietLucas TrepsBrian W. WongPauline de ZeeuwGuy EelenAdrian L. HarrisJoanna KaluckaEsther Bridges
- Journals
- Journal of Biological Chemistry (1 paper)Physiological Reviews (1 paper)Nature reviews. Cancer (48 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Ulrike Harjes
58 papers receiving 902 citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 330
- Molecular Biology 515
- Immunology 136
- Biochemistry 40
- Oncology 113
Countries citing papers authored by Ulrike Harjes
This map shows the geographic impact of Ulrike Harjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Harjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Harjes more than expected).
Fields of papers citing papers by Ulrike Harjes
This network shows the impact of papers produced by Ulrike Harjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Harjes. The network helps show where Ulrike Harjes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulrike Harjes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 0 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 18 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 4 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2016 | 43 | |
| 19 | 2016 | 5 | |
| 20 | 2011 | 16 |
About Ulrike Harjes
Ulrike Harjes is a scholar working on Cancer Research, Immunology and Oncology, having authored 60 papers that have together received 907 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (7 papers), Cancer, Lipids, and Metabolism (7 papers), CAR-T cell therapy research (6 papers), Epigenetics and DNA Methylation (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (330 citations), Molecular Biology (515 citations) and Immunology (136 citations). Ulrike Harjes has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Peter Carmeliet, Lucas Treps, Brian W. Wong, Pauline de Zeeuw, Guy Eelen, Adrian L. Harris, Joanna Kalucka, Esther Bridges, Karim Bensaad and Barbara A. Fielding. Their work appears in journals such as Journal of Biological Chemistry, Physiological Reviews and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.